- Exciting News! We’ve partnered with Affirm and CareCredit to offer flexible payment plans, making early cancer detection even more accessible.
Industry Leading
Screening Technology
Precision Rapid Cancer Testing
Revolutionary Cancer Testing
OncoSure provides rapid cancer testing for all types of cancers with accurate, non-invasive detection in just 24 hours.
All Human Cancers
Comprehensive testing for every type of cancer with advanced genomic analysis
Results in 24 Hours
Get your results the next day, no weeks of waiting, no anxiety limbo
97.7% Accuracy
Industry-leading precision with validated clinical-grade testing protocols
For Providers
OncoSure’s
Advanced Cancer Screening
Technology.
Detecting cancer can be challenging due to limited existing screening tests, long turnaround times, high costs, and invasive procedures. OncoSure’s innovative technology allows for early detection, even at stage -1, and provides crucial information for guiding further imaging tests with our detailed Oncosome count.
OncoSure’s advanced cancer screening technology utilizes rapid in situ hybridization and DNA fluorescent probes, offering comprehensive cancer screening with high accuracy. Our approach includes a rapid SITU Hybridization Platform, DNA Fluorescent Probes for ploidy detection, and inexpensive density gradient and low sequential centrifugation, which enable comprehensive screening for aneuploidy of all chromosomes.
Why Oncosure
Choosing the right cancer detection method is crucial for timely and accurate diagnosis. Here's why OncoSure stands out:
24 Hours
Rapid Results Get results in just 24 hours, compared to the 2-3 weeks typical with other tests.
97.77%
Unmatched Precision Backed by clinical studies with 97.77% accuracy across all cancer stages.
All Cancers
Comprehensive Screening Identifies traces of all human cancers, so you can take control of your health today!
Non-Invasive
One blood draw One blood draw, no painful procedures. Simple and comfortable process for patient.
Cost-Effective
Insurance & Financing Available Priced 61% lower than other cancer screening tests. Most major insurance plans accepted.
Perfect Score
COLA Accredited COLA-accredited laboratory, earning a perfect score on its most recent inspection.
What Our Customers Say...
Hear directly from our customers about their experience with OncoSure
About OncoSure
Our Mission is to Revolutionize Cancer Detection.
The best way to fight cancer is to catch it early. Regular screenings dramatically improve your chances of a better outcome. Effective screenings can:
- Detect cancer early, giving you a better chance at successful treatment.
- Lower your risk of dying from cancer through regular monitoring.
- Provide fast results, so you can take action sooner.
We’re committed to staying at the forefront of early cancer detection—leveraging both current science and emerging research to keep improving patient outcomes.
Early Detection Leader
Revolutionizing Cancer Care Through Innovation
97.77%
Detection Accuracy Early detection saves lives
24 Hours
Rapid Results Fast turnaround for urgent care
7500+
Screened Nationwide Trusted by patients and providers
About TruView DX
Headquartered in Greenville, South Carolina, TruView DX is a precision-diagnostics brand of TruView Diagnostics, LLC. We develop and deliver advanced laboratory testing designed to improve early detection and clinical decision-making.
Our flagship product, the OncoSure® Cancer Screening Test, uses molecular analysis to identify cancer-associated biomarkers with exceptional accuracy — providing results in as little as 24 hours.
At TruView DX, we combine scientific innovation with compassionate care to empower patients and healthcare providers with actionable insights when they matter most.
Our Expert Team
World-Class Scientists & Laboratory Professionals
Our team of board-certified physicians, molecular scientists, and laboratory professionals brings decades of experience in molecular diagnostics, pathology, and precision medicine to deliver the highest quality testing services.
Double Board-Certified
Dr. Phoutthasone Thirakul, MD
Laboratory Director
Pathology & Forensic Medicine
Education:
University of California, San Diego (MD)
University of South Florida (Fellowship)
Areas of Expertise:
Anatomic & Clinical Pathology
Forensic Pathology
Laboratory Operations
Oversees all clinical and operational aspects of the laboratory, ensuring compliance with regulatory standards and maintaining the highest levels of diagnostic accuracy.
CLIA Supervisor
Stephanie Altidort
General Supervisor, Molecular Pathology
Molecular Diagnostics & Genomics
Education:
Florida Atlantic University (BS Neuroscience)
Areas of Expertise:
High-Complexity Testing
Quality Control
Staff Management
Supervises high-complexity molecular testing procedures and ensures compliance with CLIA regulatory standards and laboratory accreditation requirements.
20+ Years Experience
William Wysock
Molecular Scientist
Validation & Process Development
Education:
Catholic University of America (MS Biology)
Loyola University (BA Writing)
Areas of Expertise:
Method Validation
NGS Technologies
Six Sigma Quality
Oversees validation processes and complex technical inquiries, with extensive experience in molecular methodologies and regulatory compliance.
Don't Wait for Symptoms! Ask Your Doctor About OncoSure.
Your doctor can help you decide when to get screened, but OncoSure gives you a head start. Here are four common cancers where early detection makes all the difference.
Lung Cancer
If you’re a smoker over 50, OncoSure may detect early signs, even before changes appear on scans.
Cervical Cancer
Women 21 and older should get regular cervical screenings. OncoSure offers an additional way to monitor your health.
Breast Cancer
Mammograms are recommended starting at age 40. OncoSure offers added insight between screenings or when symptoms are unclear.
Colon Cancer
Colonoscopies are vital starting at age 45. OncoSure may help detect early changes before you're eligible, or in between routine screenings.
Genetic Testing Services
Precision Genetic Insights for a Healthier Future
Beyond oncology, we offer comprehensive genetic testing services to optimize your healthcare journey. From personalized medication selection to disease risk assessment, unlock the power of your DNA for better health decisions.
Pharmacogenomics (PGx)
Optimize medication selection and dosing based on your genetic profile for safer, more effective treatment.
- Drug Response Analysis
- Dosing Optimization
- Side Effect Prediction
Genetic Wellness Panel
Comprehensive health risk assessment covering diabetes, obesity, allergies, and addiction.
- Disease Risk Assessment
- Lifestyle Insights
- Preventive Guidance
Advanced PCR Diagnostics
Highly sensitive detection for UTI, STI, wound and respiratory infections with antibiotic resistance.
- Rapid Pathogen ID
- Resistance Testing
- Targeted Treatment
Genetic Predisposition
Comprehensive risk evaluation for cancer, cardiovascular, neurological, autoimmune & hereditary conditions.
- Cancer + Multi-Disease Analysis
- Risk Stratification
- Family Planning Insights
Comprehensive Genetic Testing Solutions
